Skip to content

The Effect of L-Carnitine on the Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography in Heshmat Hospital in 2017

The Effect of L-Carnitine on the Prevention of Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography in Heshmat Hospital in 2017:a Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180921041079N1
Enrollment
143
Registered
2019-03-19
Start date
2018-11-22
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac patients are candidates for angiography. Atherosclerotic heart disease of native coronary artery

Interventions

Intervention 1: Intervention group: From the 24 hours before the coronary artery bypass graft surgery, 3000 milligrams of L-carnitine solution (1 g per 10 ml) will be given at intervals of 8 hours. Af

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients who Undergo Elective Angiography and PCI After Approval of the Plan in 1396 Will be Located at Rasht Medical Center. Patient Satisfaction: The Willingness to Participate in the Study and Sampling

Exclusion criteria

Exclusion criteria: ST elevation MI Pregnancy History of CABG in the last 6 months History of PCI in the last 6 months Cardiogenic shock Simultaneous use of nephrotoxic drugs Recent exposure to contrast material (from 2 days before 2 days later) Renal transplantation biography Thyroid disorders Corticosteroids LVEF<35% Patients who have not received full doses of medication after entering the study due to Digestive complications or incompleteness of the drug will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Contrast Nephropathy. Timepoint: L carnitine is given 24 hours before coronary angiography and then every 8 hours. Method of measurement: Serum creatinine, Glomerular filtration degree, Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbdulhassan schnuculy taze

Rasht University of Medical Sciences

E.Ramezanzade@gums.ac.ir+98 13 3361 8177

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026